Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gregory D Curfman

Showing results (21-30 of 67) with videos related to

Pageof 7
Sort By:
The New England Journal of Medicine|October 13, 2006
Blueprint for a stronger Food and Drug AdministrationGregory D Curfman, Stephen Morrissey, Jeffrey M Drazen
The New England Journal of Medicine|February 24, 2006
Expression of concern reaffirmedGregory D Curfman, Stephen Morrissey, Jeffrey M Drazen
The New England Journal of Medicine|September 7, 2007
No child left uncoveredGregory D Curfman, Stephen Morrissey, Jeffrey M Drazen
The New England Journal of Medicine|August 16, 2008
Cardiac transplantation in infantsGregory D Curfman, Stephen Morrissey, Jeffrey M Drazen
The New England Journal of Medicine|January 4, 2008
A pivotal medical-device caseGregory D Curfman, Stephen Morrissey, Jeffrey M Drazen
The New England Journal of Medicine|January 9, 2008
Physicians and executionGregory D Curfman, Stephen Morrissey, Jeffrey M Drazen
Clinical Therapeutics|September 4, 2023
The US Supreme Court and Affirmative Action: The Negative Impact on the Physician WorkforceMarcia M Boumil, Paul Beninger, Gregory D Curfman
The New England Journal of Medicine|February 13, 2003
Notice of retractionGregory D Curfman, Stephen Morrissey, Jeffrey M Drazen
The New England Journal of Medicine|April 29, 2011
Prescriptions, privacy, and the First AmendmentGregory D Curfman, Stephen Morrissey, Jeffrey M Drazen
The New England Journal of Medicine|January 24, 2006
Expression of concern: Sudbø J et al. DNA content as a prognostic marker in patients with oral leukoplakia. N Engl J Med 2001;344:1270-8 and Sudbø J et al. the influence of resection and aneuploidy on mortality in oral leukoplakia. N Engl J Med 2004;350:1405-13Gregory D Curfman, Stephen Morrissey, Jeffrey M Drazen
Pageof 7

Showing results (21-30 of 67) with videos related to

Sort By:
Pageof 7
The New England Journal of Medicine|October 13, 2006
Blueprint for a stronger Food and Drug AdministrationGregory D Curfman, Stephen Morrissey, Jeffrey M Drazen
The New England Journal of Medicine|February 24, 2006
Expression of concern reaffirmedGregory D Curfman, Stephen Morrissey, Jeffrey M Drazen
The New England Journal of Medicine|September 7, 2007
No child left uncoveredGregory D Curfman, Stephen Morrissey, Jeffrey M Drazen
The New England Journal of Medicine|August 16, 2008
Cardiac transplantation in infantsGregory D Curfman, Stephen Morrissey, Jeffrey M Drazen
The New England Journal of Medicine|January 4, 2008
A pivotal medical-device caseGregory D Curfman, Stephen Morrissey, Jeffrey M Drazen
The New England Journal of Medicine|January 9, 2008
Physicians and executionGregory D Curfman, Stephen Morrissey, Jeffrey M Drazen
Clinical Therapeutics|September 4, 2023
The US Supreme Court and Affirmative Action: The Negative Impact on the Physician WorkforceMarcia M Boumil, Paul Beninger, Gregory D Curfman
The New England Journal of Medicine|February 13, 2003
Notice of retractionGregory D Curfman, Stephen Morrissey, Jeffrey M Drazen
The New England Journal of Medicine|April 29, 2011
Prescriptions, privacy, and the First AmendmentGregory D Curfman, Stephen Morrissey, Jeffrey M Drazen
The New England Journal of Medicine|January 24, 2006
Expression of concern: Sudbø J et al. DNA content as a prognostic marker in patients with oral leukoplakia. N Engl J Med 2001;344:1270-8 and Sudbø J et al. the influence of resection and aneuploidy on mortality in oral leukoplakia. N Engl J Med 2004;350:1405-13Gregory D Curfman, Stephen Morrissey, Jeffrey M Drazen
Pageof 7